Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Akero Initiates Phase 2b HARMONY Study of Efruxifermin for NASH

americanpharmaceuticalreviewMarch 01, 2021

Tag: HARMONY , Akero , NASH , Efruxifermin

PharmaSources Customer Service